Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Review article: refractory distal colitis -- explanations and options

M G Griffin1, P B Miner

  • 1Department of Medicine, University of Kansas Medical Center, Kansas City 66160-7350. USA.

Alimentary Pharmacology & Therapeutics
|February 1, 1996
PubMed
Summary

Standard treatments for distal colitis often fail due to reliance on oral therapies. This review explores reasons for treatment resistance and discusses novel therapeutic approaches for refractory distal colitis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prucalopride induces high-amplitude propagating contractions in the colon of patients with chronic constipation: a randomized study.

Neurogastroenterology and motility·2016
Same author

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.

Alimentary pharmacology & therapeutics·2013
Same author

What is the best initial treatment and maintenance therapy for distal ulcerative colitis?

Inflammatory bowel diseases·2013
Same author

Opinion: placebos are an important aspect of studies of patients with inflammatory bowel disease.

Inflammatory bowel diseases·2013
Same author

Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.

Alimentary pharmacology & therapeutics·2011
Same author

Omeprazole-Mg 20.6 mg is superior to lansoprazole 15 mg for control of gastric acid: a comparison of over-the-counter doses of proton pump inhibitors.

Alimentary pharmacology & therapeutics·2010

Area of Science:

  • Gastroenterology
  • Inflammatory Bowel Disease Research
  • Colorectal Therapeutics

Background:

  • Distal colitis refractory to standard therapy presents a significant clinical challenge.
  • Physiological differences between the right and left colon are crucial for therapeutic strategies.
  • Over-reliance on oral therapy contributes to treatment failure in distal colitis.

Purpose of the Study:

  • To explore potential mechanisms underlying refractory distal colitis.
  • To address the limitations of current therapeutic approaches.
  • To review emerging therapies for distal colitis.

Main Methods:

  • Literature review of existing studies on distal colitis.
  • Analysis of physiological differences in colonic segments.

Related Experiment Videos

  • Evaluation of therapeutic delivery systems and adverse effects.

    • Main Results:

    • Oral therapy over-reliance and suboptimal dosing are key reasons for treatment failure.
    • Mesalazine-induced colitis can mimic worsening disease, complicating diagnosis.
    • Numerous endogenous and exogenous factors can exacerbate underlying inflammatory bowel disease.

    Conclusions:

    • Targeted delivery systems and appropriate dosing are essential for effective distal colitis treatment.
    • Clinicians must be aware of adverse effects of standard therapies.
    • Investigational therapies offer future hope for managing refractory distal colitis.